ATM
ataxia telangiectasia mutated
ATM; ataxia telangiectasia mutated; ATA, ataxia telangiectasia mutated (includes complementation groups A, C and D) , ATC, ATD, ATDC; serine-protein kinase ATM; TEL1; telomere maintenance 1; homolog (S. cerevisiae); TELO1; AT mutated; A-T mutated; TEL1,;
ATMIN
ATM interactor
ATMIN; ATM interactor; ASCIZ; ZNF822; ATM INteracting protein; zinc finger protein 822; ATM/ATR-Substrate Chk2-Interacting Zn++-finger protein; ATM/ATR-substrate CHK2-interacting zinc finger protein; ATM/ATR-substrate CHEK2-interacting zinc finger protein;
BRAT1
BRCA1-associated ATM activator 1
BRAT1; BRCA1-associated ATM activator 1; BAAT1; RMFSL; C7orf27; HEAT repeat-containing protein C7orf27; BRCA1-associated protein required for ATM activation protein 1;
One of the 54th ASH Annual Meeting Presentations: SGEN' Antibody-drug Conjugate Hit a Hope for the Treatment of AML
This year as usual on the 54th American Society of Hematology (ASH) annual meeting, there were lot of new findings and explorations were presented and shared. One of them, the Seattle Genetics ($SGEN) gave a brief presentations on SGN-CD33A, which is one of its early-stage next-generation antibody-d...
Fluorescent Cattle—Gives New Hope for Cancer Treatment
Do you drink milk every day? Does it pure or have some additives? We all know that manufacturers in dairy industry have thought about all kinds of ways to make their products attractive to their customers. But have you ever thought that there might be fluorescent cattle? Can you imagine what does it...
Garlic And Broccoli Were Found to Help Improve Cancer Treatment
Our immune system is developed to remove things that are alien to our bodies. However. Sometimes, some types of cancer cells contain mechanisms that block the immune systems ability to recognize them. And some stimulating molecules can over-activate the immune system and ...
A New Patent of Monoclonal Antibodies for the Treatment of Serious Diseases Research and Development Registered
On Dec. 21, 2012, one of our peer companies, Immunomedics, Inc. (Nasdaq:IMMU) announced that it has received notice its patent application for Anti-CD19 antibodies which would be issued as US patent No. 8,337,840 on Dec. 25, 2012. IMMU primarily attaches importance to the development o...
